146 related articles for article (PubMed ID: 36448271)
1. P53 immunolabeling in EUS-FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy.
Oshima M; Okano K; Kamada H; Suto H; Ando Y; Ibuki E; Ishikawa R; Masaki T; Haba R; Suzuki Y
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):802-814. PubMed ID: 36448271
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
3. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
[TBL] [Abstract][Full Text] [Related]
4. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J
J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
[TBL] [Abstract][Full Text] [Related]
6. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.
Suzuki R; Irie H; Takagi T; Sugimoto M; Konno N; Sato Y; Watanabe K; Nakamura J; Marubashi S; Hikichi T; Ohira H
BMC Cancer; 2018 Oct; 18(1):974. PubMed ID: 30314433
[TBL] [Abstract][Full Text] [Related]
7. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
[TBL] [Abstract][Full Text] [Related]
8. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
9. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases.
Senoo J; Mikata R; Kishimoto T; Hayashi M; Kusakabe Y; Yasui S; Yamato M; Ohyama H; Sugiyama H; Tsuyuguchi T; Yoshitomi H; Ohtsuka M; Maeda J; Ota S; Nakatani Y; Kato N
Pancreatology; 2018 Mar; 18(2):176-183. PubMed ID: 29305088
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens.
Razzano D; Bouza SJ; Hernandez PV; Wang M; Robert ME; Walther Z; Cai G
Cancer Cytopathol; 2022 Sep; 130(9):726-734. PubMed ID: 35511415
[TBL] [Abstract][Full Text] [Related]
12. Impact of p53 and PDGFR-β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer.
Kurahara H; Maemura K; Mataki Y; Sakoda M; Shinchi H; Natsugoe S
World J Surg; 2016 Aug; 40(8):1977-84. PubMed ID: 26940582
[TBL] [Abstract][Full Text] [Related]
13. Clinical dilemma of endoscopic ultrasound-guided fine needle aspiration for resectable pancreatic body and tail cancer.
Kitano M; Minaga K; Hatamaru K; Ashida R
Dig Endosc; 2022 Jan; 34(2):307-316. PubMed ID: 34437750
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens.
Yu S; Doyle LA; Hornick JL; Mito JK
Cancer Cytopathol; 2024 Feb; 132(2):87-95. PubMed ID: 38054349
[TBL] [Abstract][Full Text] [Related]
15. Needle tract seeding following endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a report of two cases.
Matsui T; Nishikawa K; Yukimoto H; Katsuta K; Nakamura Y; Tanaka S; Oiwa M; Nakahashi H; Shomi Y; Haruki Y; Taniguchi K; Shimomura M; Isaji S
World J Surg Oncol; 2019 Aug; 17(1):134. PubMed ID: 31382964
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preoperative diagnostic methods for resectable pancreatic cancer: a diagnostic capability and impact on the prognosis of endoscopic ultrasound-guided fine needle aspiration.
Maruta A; Iwashita T; Yoshida K; Uemura S; Yasuda I; Shimizu M
BMC Gastroenterol; 2021 Oct; 21(1):382. PubMed ID: 34663214
[TBL] [Abstract][Full Text] [Related]
17. The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?
Park JS; Lee JH; Song TJ; Lee JS; Jo SJ; Oh DW; Song KB; Hwang DW; Park DH; Lee SS; Kim SC; Seo DW; Lee SK; Kim MH
Surg Endosc; 2022 May; 36(5):3192-3199. PubMed ID: 34254183
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy.
Beane JD; House MG; Coté GA; DeWitt JM; Al-Haddad M; LeBlanc JK; McHenry L; Sherman S; Schmidt CM; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD
Surgery; 2011 Oct; 150(4):844-53. PubMed ID: 22000199
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials.
Janssen QP; Quispel R; Besselink MG; Bonsing BA; Bruno MJ; Doukas M; Sarasqueta AF; Homs MYV; van Hooft JE; van Tienhoven G; van Velthuysen MF; Verheij J; Voermans RP; Wilmink JW; Groot Koerkamp B; van Eijck CHJ; van Driel LMJW;
HPB (Oxford); 2023 Oct; 25(10):1161-1168. PubMed ID: 37211461
[TBL] [Abstract][Full Text] [Related]
20. Applications of endoscopic ultrasound in pancreatic cancer.
Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
